EMERALD INNOVATIONS, INC: public contracts won without a rival in United States: 1 uncontested awards; 100% of its awards; 0 without a competition; 1 single bid.
Assay record ASY-US-19OXLL71SO · Cite as: Assay Systems, “EMERALD INNOVATIONS, INC: public contracts won without a rival in United States”, https://assay-systems.com/register/us/uncontested/s/emerald-innovations-inc/
EMERALD INNOVATIONS, INC won 1 of its 1 public contract awards in United States without a rival from 2023-12-06 to 2023-12-06, worth $2.0M: 0 without a competition and 1 after a competition that drew a single bid. 1 buyer awarded it without a rival, the largest Food and Drug Administration with 1.
An award is uncontested when the buyer had no rival offer to weigh: it was made without a competition (direct award, negotiated procedure without a call for tenders, sole-source or advance-notice contract), or a competition was held and only one bid arrived. Every count below is built award by award from the official notices. Awards to individuals are not included.
Food and Drug Administration gave EMERALD INNOVATIONS, INC 1 award: 0 without a competition, 1 after a competition with a single bid. First 2023-12-06, latest 2023-12-06.
| Date | Buyer | How | Value | Stated reason |
|---|---|---|---|---|
| 2023-12-06 | Food and Drug Administration 75F40124C00013 | Single bid FULL AND OPEN COMPETITION | $2.0M | — |
Every uncontested award in United States · All countries
Source: USAspending.gov prime award transactions (contracts). Awards are matched to their buyer and supplier as published. Updated 17 October 2026.